PSMD1 and Parkinson disease: However, unlike Parkinson’s disease, where the activity of proteins in this pathway are decreased, causing mitochondrial dysfunction due to mutations or other factors [46], in the current study, these proteins were increased, suggesting a mechanism of mitochondrial protection induced in the hypoxic cells treated with S1 protein.